Skip to main content
LLY
NYSE Life Sciences

Lilly to Acquire Merida Biosciences to Advance Autoimmune and Allergic Disease Treatments

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1,171
Mkt Cap
$1.106T
52W Low
$712.05
52W High
$1,292.65
52W Position info
64% above low
Off High info
9.4% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

LLY sits 64% above its 52-week low of $712.05.

Summary

Lilly is acquiring Merida Biosciences to expand its pipeline in serious autoimmune and allergic diseases. The deal is worth up to $2.88 billion in cash, including an upfront payment and contingent milestone payments. The acquisition adds a new therapeutic area to Lilly's portfolio, which has been heavily focused on diabetes and obesity. This follows a period of strong clinical and commercial momentum, including Q2 revenue growth of 48% to $23B. The acquisition could strengthen Lilly's long-term growth beyond its current blockbuster franchises.

Updates

  1. · Wiseek News — The deal adds Phase 1 biologic MER511 and preclinical immunology and allergy programs, expected to close in Q4 2026 pending approvals.

At the time of this announcement, LLY was trading at $1,171.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.1T. The 52-week trading range was $712.05 to $1,292.65. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 18, 2026, 3:04 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,381.18
Real-time Price: $1,370.00 info
Change: -$11.18 (-0.81%) info
Market Cap: $1.301T info
LLY
Nov 17, 2026, 11:18 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,416.23
Real-time Price: $1,370.00 info
Change: -$46.22 (-3%) info
Market Cap: $1.301T info
LLY
Nov 16, 2026, 6:52 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,455.36
Real-time Price: $1,370.00 info
Change: -$85.36 (-6%) info
Market Cap: $1.301T info
LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,370.00 info
Change: -$82.69 (-6%) info
Market Cap: $1.301T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,370.00 info
Change: -$77.85 (-5%) info
Market Cap: $1.301T info